Saint-Gobain to Build New Glass Wool Production Plant in Japan

Saint-Gobain, a designer, manufacturer and distributor of building materials, has planned to construct a new plant for producing glass wool in the Kansai region, Japan.

The company will receive support from Mag-Isover, a subsidiary of Saint-Gobain and a manufacturer of insulation materials. Total investment for the construction is approximately €140 million.

The facility is estimated to produce 60,000 t of glass wool and the operation will commence by the end of 2013. The quantity will add to the production of Mag-Isover’s facilities. This increases the total glass wool production capacity of Saint-Gobain to 150,000 t.

In addition to the construction of a new glass wool facility, Saint-Gobain has taken an initiative for the Russian expansion. Saint-Gobain’s insulation division, Isover has acquired a manufacturer of rock wool insulation materials in Tcheliabinsk, Russia.

The acquisition of Linerock will help Isover in geographical expansion and also support the enhancement of its product range. This enables the company to attain a significant position in the rapidly growing insulation market of Russia.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). Saint-Gobain to Build New Glass Wool Production Plant in Japan. AZoM. Retrieved on November 24, 2024 from https://www.azom.com/news.aspx?newsID=30009.

  • MLA

    Chai, Cameron. "Saint-Gobain to Build New Glass Wool Production Plant in Japan". AZoM. 24 November 2024. <https://www.azom.com/news.aspx?newsID=30009>.

  • Chicago

    Chai, Cameron. "Saint-Gobain to Build New Glass Wool Production Plant in Japan". AZoM. https://www.azom.com/news.aspx?newsID=30009. (accessed November 24, 2024).

  • Harvard

    Chai, Cameron. 2019. Saint-Gobain to Build New Glass Wool Production Plant in Japan. AZoM, viewed 24 November 2024, https://www.azom.com/news.aspx?newsID=30009.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.